Global Blood Therapeutics
-
Pfizer, Global Blood Therapeutics in agreement
Pfizer will acquire all the outstanding shares of GBT for $68.50 per share in cash Pfizer and Global Blood Therapeutics…
Read More »
Pfizer will acquire all the outstanding shares of GBT for $68.50 per share in cash Pfizer and Global Blood Therapeutics…
Read More »